GlassScriptPhysician profile
Jenny L Shaffer
NPI 1073838322
$632.81
in general payments reported to CMS, 2019-2025
10 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $122 · 2023: $222 · 2024: $180 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $239.35 | 2022-2024 | Prolaris |
| Novocure INC. | $98.34 | 2022-2024 | Optune |
| Novartis Pharmaceuticals Corporation | $67.84 | 2024-2025 | |
| Boston Scientific Corporation | $59.54 | 2023-2024 | Spaceoar Vue System - 10ml |
| Gt Medical Technologies, INC | $39.08 | 2025 | Gammatile |
| Bayer Healthcare Pharmaceuticals INC. | $38.94 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $27.56 | 2025 | Orgovyx |
| Regeneron Healthcare Solutions, INC. | $26.31 | 2024 | Libtayo |
| Teleflex LLC | $19.31 | 2025 | Barrigel |
| Elekta, INC. | $16.54 | 2023 | Elekta Unity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Shaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.